SOPHiA GENETICS SA
Last updated September 27, 2026
Organization details
- Legal name
- SOPHiA GENETICS SA
- Ownership
- Public
- Status
- Active
- SIC code
- 7374 — Services-Computer Processing & Data Preparation
- Jurisdiction of incorporation
- Switzerland
- Headquarters city
- Rolle
- Headquarters country
- Switzerland
- Fiscal year end
- December
- Ticker symbol
- SOPH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001840706
Board of directors
-
Didier Hirsch · DirectorSince 2026
-
Jean-Michel Cossery · DirectorSince 2026
-
Jurgi Camblong · Director · Executive ChairmanSince 2026
-
Kathy L. Hibbs · DirectorSince 2026
-
Ross Muken · Director · Chief Executive OfficerSince 2026
-
Tomer Berkovitz · DirectorSince 2026
-
Troy Cox · DirectorSince 2026
-
Vincent Ossipow · DirectorSince 2026
Chief executives
Jurgi Camblong
· Chief Executive Officer
Dates unknown
Ross Muken
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 5 other boards.
- via Kathy L. Hibbs and Troy Cox
- via Didier Hirsch
- via Didier Hirsch
- via Troy Cox
- via Troy Cox
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $99,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $4,385,339
- 137 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 21, 2026 | CARDOZA GEORGE Officer (Chief Financial Officer) | Open-market sale | −774 | $8.33 | $6,447 |
| Sep 21, 2026 | Ross Muken Director, Officer (Chief Executive Officer) | Open-market sale | −422 | $8.33 | $3,515 |
| Sep 14, 2026 | Menu Philippe Officer (Chief Medical Officer) | Open-market sale | −5,000 | $7.88 | $39,417 |
| Sep 14, 2026 | Xu Zhenyu Officer (Chief Scientific Officer) | Open-market sale | −4,000 | $7.88 | $31,538 |
| Sep 11, 2026 | Van Well Daan Officer (Chief Legal Officer) | Open-market sale | −6,168 | $7.63 | $47,089 |
| Sep 10, 2026 | Jurgi Camblong Director, Officer (Executive Chairman) | Open-market sale | −8,500 | $7.66 | $65,120 |
| Sep 8, 2026 | Kathy L. Hibbs Director | Open-market sale | −6,250 | $8.13 | $50,818 |
| Aug 27, 2026 | Xu Zhenyu Officer (Chief Scientific Officer) | Open-market sale | −10,000 | $8.91 | $89,096 |
| Aug 25, 2026 | Kathy L. Hibbs Director | Open-market sale | −6,250 | $8.68 | $54,233 |
| Aug 25, 2026 | Menu Philippe Officer (Chief Medical Officer) | Open-market sale | −5,000 | $8.68 | $43,397 |
| Aug 24, 2026 | Verma Abhimanyu Officer (Chief Technology Officer) | Open-market sale | −5,000 | $8.80 | $44,000 |
| Aug 21, 2026 | Xu Zhenyu Officer (Chief Scientific Officer) | Open-market sale | −5,408 | $8.40 | $45,447 |
| Aug 20, 2026 | Xu Zhenyu Officer (Chief Scientific Officer) | Open-market sale | −4,592 | $8.41 | $38,609 |
| Aug 19, 2026 | Xu Zhenyu Officer (Chief Scientific Officer) | Open-market sale | −10,000 | $7.94 | $79,427 |
| Aug 19, 2026 | Valente Manuela Officer (Chief People Officer) | Option exercise | +10,000 | $3.20 | $32,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.